1.Development and Application of Organism Weak Magnetic Field Analytic Technology
Jing WANG ; Benli XIA ; Qingtao PENG
Chinese Medical Equipment Journal 1989;0(03):-
The production and the developing process , the technical principle and the characteristic of organism weak magnetic field analytic technology are elaborated, as well as the application on health maintenance testing and psychologi- cal testing in recent years. It is pointed that organism weak magnetic field analytic technology has high clinical reference value and the application value on some aspects, including sub-health state analysis, equilibrium state analysis of alimen- tation and metabolic balance, influencing analysis of heredity and environmental deleterious factors on health, analysis of tumor susceptibility, early warning and predict of body's potential disease and psychological condition examination.
2.Clinical treatment and analysis of minimally invasive percutaneous nephrolithotomy
Jingqiu YANG ; Derong ZHOU ; Jie CHEN ; Youbin PENG ; Qingtao YANG
Chinese Journal of Postgraduates of Medicine 2012;(z1):10-11
Objective To investigate the complications of minimally invasive percutaneous nephrolithotomy (PCNL) and their countermeasures.Methods The datum of 265 cases who underwent PCNL in our hospital.Among the 265 cases of PCNL,serious complications occurred in 13 cases.Of the 13 cases,4 cases had massive hemorrhage,2 case had colon perforation,1 case had serious urinary extravasation,6 cases had febricity.Results The incidence of serious complications was 4.91%(13/265),all patients were cured by corresponding treatment and no death in the cases.Conclusions Adequate preoperative preparation in PCNL and strict surgical indications were good for complications reduction.Serious complications should be detected early and treated correspondingly.
3.Quality indicators in clinical laboratories:past, status quo and future
Rui ZHOU ; Yufang LIANG ; Tao PENG ; Jianping ZHANG ; Qingtao WANG
Chinese Journal of Laboratory Medicine 2016;(1):60-63
In recent years , with the development of error theory and the requirements of the international accreditation bodies , the quality indicators ( QIs) have become one of the important tools in the laboratory quality management .To explore the evolution and origin of QIs , the status and the future of QIs will be helpful for us to understand and to use the QIs .
4.Association of insulin resistance with common carotid arterial stiffness in hemodialysis patients
Yilun ZHOU ; Zexing YU ; Huimin JIA ; Qingtao WANG ; Juan MENG ; Fang SUN ; Lijie MA ; Jing LIU ; Bin HAN ; Qianmei SUN ; Liren PENG
Chinese Journal of Nephrology 2008;24(4):249-252
Objective To investigate the association between arterial stiffness of the common carotid artery(CCA)and insulin resistance in hemodialysis patients. Methods Arterial stiffness index β of CCA was evaluated by an ultrasonic phase-lock Echo-tracking system in 80stable non-diabetic hemodialysis patients.Insulin resistance was detected by the homeostasis model assessment method(HOMA-IR).Plasma hemoglobin,serum albumin,total cholesterol,high density lipoprotein,low density lipoprotein,triglyceride,lipoprotein(a),ApoA1,ApoB,CRP,calcium,phosphorus and creatinine were determined by standard methods. Results The stiffness index β was 11.41±4.13 in patients with previous cardiovascular disease(CVD)and 9.75±3.63 in those without CVD(P<0.05).The stiffness index β was positively correlated with HOMA-IR(r=0.321,P<0.01),as well as with age(r=0.376,P<0.01),pulse pressure(r=0.267,P<0.05),and duration of hemodialysis(r=0.219,P<0.05).In stepwise multiple regression analysis,HOMA-IR(β=0.228,P<0.05)and age(β=0.308,P<0.01)were identified as significant independent variables for stiffness index β of CCA. Conclusions Insulin resistance is associated with aaefial stiffness in nondiabetic hemodialysis patients.The increased arterial stiffness may be the link between insulin resistance and cardiovascular morbidity as well as mortality in hemodialysis patients.
5.The efficacy comparison of spring coil embolization under auxiliary technology and stent implantation spring coil embolization in the treatment of intracranial aneurysms
Qingtao ZHANG ; Peng CHEN ; Wei ZHOU
Chinese Journal of Endocrine Surgery 2019;13(4):315-319
Objective To compare the clinical effect of spring coil embolization under auxiliary technology and stent implantation spring coil embolization in treatment of intracranial aneurysms.Methods The medical records of 102 patients with intracranial aneurysms who were treated by endovascular embolization were retrospectively analyzed.These patients were divided into stent implantation spring coil embolization (n=58) and aux iliary spring coil embolization group(n=44) according to different treatment methods.The therapeutic effect of postoperative aneurysm embolization for patients of the two groups was evaluated.The postoperative hospitalization time,NIHSS score,ADL score and prognosis of patients in the two groups 6 months after treatment were compared.The incidence of complications of patients in the two groups was compared.Results There was no significant difference between the two groups about complete embolization rate,sub-total embolization rate and partial embolization rate after aneurysm surgery(72.73%,20.45%,6.82% vs 68.97%,25.86%,5.17%)(P>0.05).The postoperative hospitalization time of patients in the assistive coil embolization group (10.45±2.32) d was significantly less than that in the stent-assisted coil embolization (12.97±2.56) d (P<0.05),but there was no significant difference in postoperative NIHSS score and ADL score between the two groups [(6.63±3.81),(60.12±9.80) vs (8.35±4.03),(59.63±9.47)(P>0.05)].The recovery rate of patients in the assistive coil embolization group (68.18%) was significantly higher than that in the stent-assisted coil embolization group (55.17%) (P<0.05),while the mortality rate (0%) was significantly lower than that in the stent-assisted coil embolization group (6.90%) (P<0.05).The incidence of complications such as intraoperative cerebral vasospasm,postoperative gastrointestinal bleeding and postoperative cerebral infarction (9.09%,6.82%,4.55%) was significantly lower in the assistive coil embolization group than that in the stent-assisted coil embolization group (25.86%,20.69%,17.24%) (P<0.05),while there was no significant difference in aneurysm recurrence rate between the two groups (13.64% vs 10.34%)(P>0.05).Conclusion Compared with stent implantation spring coil embolization,the spring coil embolization under auxiliary technology can significantly shorten the postoperative hospitalization time,improve the prognosis and reduce the incidence of postoperative complications.
6.Effect of basic fibroblast growth factor on reducing intracranial pressure in rats after abdominal hypertension
Peng CHEN ; Qingtao ZHANG ; Wei ZHOU ; Yongbing DENG ; Lianyang ZHANG ; Xi HU
Chinese Journal of Trauma 2020;36(5):455-462
Objective:To investigate the role of basic fibroblast growth factor (bFGF) in decreasing intracranial pressure in rats after intra-abdominal hypertension (IAH).Methods:A total of 60 healthy SD rats were selected for the experiment. Secondary IAH rat models were established by hemorrhagic shock/resuscitation, followed by injecting nitrogen into the peritoneal cavity of the rats to maintain an intra-abdominal pressure of 12mmHg and above. According to the random number table, the rats were divided into control group, IAH group, IAH+ bFGF group (bFGF group) and IAH+ bFGF+ PD173074 group (antagonist group), with 15 rats per group. Indicators were measured 4 hours after injury, including intracranial pressure, brain morphological observation, apparent diffusion coefficient (ADC) value, lactic acid content of brain MRI, brain water content and Evans blue exudation. Immunofluorescence staining, Western blotting and PCR were used to detect the expressions of phosphorylate-fibroblast growth factor receptor 1, 2 (p-FGFR1, 2), Zonula occludens-1 (ZO-1), β-catenin, matrix metalloproteinases 9 (MMP9), interleukin-1β (IL-1β) in brain microvascular endothelial cells (BMECs).Results:The intracranial pressure in IAH group [(5.52±0.45)mmHg] gradually increased 4 hours after injury compared control group [(3.36±0.30)mmHg]. Compared with IAH group, the intracranial pressurein bFGF group [(4.46±0.41)mmHg] was decreased ( P<0.05). Compared with bFGF group, the intracranial pressure in antagonist group [(5.36±0.44)mmHg] was enhanced ( P<0.05). Brain morphological observations in IAH group showed swelling and obvious cerebral edema, accompanied with a small amount of subarachnoid hemorrhage. Compared with IAH group, cerebral edema and brain swelling were relieved in bFGF group, while the antagonist group still showed cerebral edema and obvious brain swelling. At 4 hours after injury, MRI examination showed that the relative ADC value in IAH group (cortex: 0.82±0.11, corpus callosum: 1.26±0.17) was lower than that in control group (cortex: 1.00±0.13, corpus callosum: 1.43±0.15)( P<0.05). Compared with IAH group, the relative ADC value in bFGF group (cortex: 0.94±0.16, corpus callosum: 1.36±0.16) was increased ( P<0.05). Compared with bFGF group, the relative ADC value in antagonist group (cortex: 0.87±0.13, corpus callosum: 1.30±0.14) was decreased ( P<0.05). Relative lactic acid content in IAH group (cortex: 15.50±2.14, corpus callosum: 10.82±1.90)was higher than that in control group (cortex: 1.00±0.23, corpus callosum: 0.70±0.20)( P<0.05). Compared with IAH group, the relative lactic acid content in bFGF group (cortex: 10.85±1.42, corpus callosum: 6.96±1.30) was decreased ( P<0.05). Compared withbFGF group, the relative lactic acid content in antagonist group (cortex: 13.71±1.61, corpus callosum: 9.12±1.52) was increased ( P<0.05). The brain water content in IAH group [(87.9±0.8)%] was higher than that in control group [(76.3±0.9)%]. Compared with IAH group, the brain water content in bFGF group [(83.2±1.0)%] was decreased( P<0.05). Compared with bFGF group, the brain water content in antagonist group[(85.4±0.8)%] was increased ( P<0.05). Evans blue exudation in IAH group [(3.22±0.29)μg/ml] was greater than that in control group [(0.42±0.22)μg/ml]( P<0.05). Compared with IAH group, the Evans blue exudation in bFGF group [(2.04±0.25)μg/ml] was decreased ( P<0.05). Compared with bFGF group, the Evans blue exudation in antagonist group [(2.92±0.20)μg/ml] was increased ( P<0.05). Compared with control group, the expression of p-FGFR1 in BMECs in IAH group was weakened 4 hours after injury, but p-FGFR2 remained unchanged, the expressions of ZO-1, β-catenin protein and mRNA were weakened, and the expressions of MMP9, IL-1β protein and mRNA were enhanced ( P<0.05). Compared with IAH group, the expressions of p-FGFR1, ZO-1, β-catenin protein and mRNA were enhancedin bFGF group, and the expressions of MMP9, IL-1β protein and mRNA were weakened as well ( P<0.05). However, the expressions of p-FGFR1, ZO-1 and β-catenin protein and mRNA in antagonist group were weaker than those in bFGF group, and the expressions of MMP9 and IL-1β protein and mRNA were stronger than those in the bFGF group ( P<0.05). Conclusion:After IAH, the rat model presents damaged blood-brain barrier, increased cerebral edema, and increased intracranial pressure, and the use of bFGF can improve these symptoms. FGFR1 of BMECs is a key receptor for bFGF to play a protective role, and its receptor inhibitor PD173074 can attenuate the protective effect of bFGF.